Utah Medical Products ( (UTMD) ) has released its Q3 earnings. Here is a breakdown of the information Utah Medical Products presented to its investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Utah Medical Products, Inc., a company specializing in healthcare devices for women and infants, develops, manufactures, and markets a wide range of medical devices recognized globally for their quality and effectiveness. In its latest earnings report, Utah Medical Products faced challenges due to global trade uncertainties, resulting in a decline in financial performance for the third quarter and first nine months of 2025 compared to the previous year. The company’s revenue, gross profit, and net income all saw declines, with revenues dropping by 2% for the quarter and 7% for the nine months. The company attributed these declines to the cancellation or delay of orders by international distributors and increased operating expenses. Despite these setbacks, Utah Medical Products maintained a strong balance sheet with no debt and continued to repurchase shares, reflecting confidence in its long-term prospects. Looking ahead, the company anticipates a challenging environment but remains committed to maintaining its financial health and operational efficiency.